Quantum-Si Expands International Distribution Network
Quantum-Si (Nasdaq: QSI) has announced a significant expansion of its international distribution network, now totaling 15 partners. The expansion covers multiple regions including Western and Eastern Europe, Asia, Middle East, Africa, South America, and the South Pacific. This strategic move, combined with the recently announced Avantor distribution agreement for North America, aims to accelerate the global adoption of their 笔濒补迟颈苍耻尘庐 product and drive revenue growth from 2025 onwards. The company is focusing on broadening access to research customers globally through these partnerships.
Quantum-Si (Nasdaq: QSI) ha annunciato una significativa espansione della sua rete di distribuzione internazionale, ora composta da 15 partner. L'espansione copre diverse regioni tra cui Europa occidentale e orientale, Asia, Medio Oriente, Africa, Sud America e Sud Pacifico. Questa mossa strategica, insieme all'accordo di distribuzione Avantor recentemente annunciato per il Nord America, mira ad accelerare l'adozione globale del loro prodotto 笔濒补迟颈苍耻尘庐 e a guidare la crescita dei ricavi a partire dal 2025. L'azienda si sta concentrando sul miglioramento dell'accessibilit脿 per i clienti della ricerca a livello globale attraverso queste collaborazioni.
Quantum-Si (Nasdaq: QSI) ha anunciado una expansi贸n significativa de su red de distribuci贸n internacional, que ahora cuenta con 15 socios. La expansi贸n abarca varias regiones, incluyendo Europa Occidental y Oriental, Asia, Medio Oriente, 脕frica, Am茅rica del Sur y el Pac铆fico Sur. Este movimiento estrat茅gico, junto con el acuerdo de distribuci贸n Avantor recientemente anunciado para Am茅rica del Norte, tiene como objetivo acelerar la adopci贸n global de su producto 笔濒补迟颈苍耻尘庐 y impulsar el crecimiento de ingresos desde 2025 en adelante. La empresa se est谩 enfocando en ampliar el acceso a clientes de investigaci贸n a nivel mundial a trav茅s de estas asociaciones.
Quantum-Si (Nasdaq: QSI)電� 順勳灛 15臧滌潣 韺岉姼雱堧 甑劚霅� 甑牅 鞙犿喌 雱ろ姼鞗岉伂鞚� 靸侂嫻頃� 頇曥灔鞚� 氚滍憸頄堨姷雼堧嫟. 鞚� 頇曥灔鞚� 靹滊秬鞕� 霃欕秬 鞙犽熃, 鞎勳嫓鞎�, 欷戨彊, 鞎勴攧毽勾, 雮, 攴鸽Μ瓿� 雮儨韽夓枒鞚� 韽暔頃� 鞐煬 歆�鞐潉 雼る９雼堧嫟. 斓滉芳 氚滍憸霅� 攵侂鞖� Avantor 鞙犿喌 瓿勳暯瓿� 頃粯頃橂姅 鞚� 鞝勲灥鞝� 鞗�歆侅瀯鞚� 2025雲勲秬韯� 鞛愳偓鞚� 笔濒补迟颈苍耻尘庐 鞝滍拡鞚� 旮�搿滊矊 毂勴儩鞚� 臧�靻嶍檾頃橁碃 靾橃澋 靹膘灔鞚� 齑夓頃橂姅 瓴冹潉 氇╉憸搿� 頃╇媹雼�. 須岇偓電� 鞚措煬頃� 韺岉姼雱堨嫮鞚� 韱淀暣 鞝� 靹戈硠 鞐瓣惮 瓿犼皾鞐� 雽�頃� 鞝戧芳鞚� 頇曤寑頃橂姅 雿� 歆戩頃橁碃 鞛堨姷雼堧嫟.
Quantum-Si (Nasdaq: QSI) a annonc茅 une expansion significative de son r茅seau de distribution international, qui compte d茅sormais 15 partenaires. Cette expansion couvre plusieurs r茅gions, y compris l'Europe de l'Ouest et de l'Est, l'Asie, le Moyen-Orient, l'Afrique, l'Am茅rique du Sud et le Pacifique Sud. Cette d茅marche strat茅gique, combin茅e avec le nouvel accord de distribution Avantor r茅cemment annonc茅 pour l'Am茅rique du Nord, vise 脿 acc茅l茅rer l'adoption mondiale de leur produit 笔濒补迟颈苍耻尘庐 et 脿 stimuler la croissance des revenus 脿 partir de 2025. L'entreprise se concentre sur l'茅largissement de l'acc猫s aux clients de recherche 脿 l'茅chelle mondiale gr芒ce 脿 ces partenariats.
Quantum-Si (Nasdaq: QSI) hat eine bedeutende Erweiterung seines internationalen Vertriebsnetzwerks bekanntgegeben, das nun insgesamt 15 Partner umfasst. Die Erweiterung erstreckt sich 眉ber mehrere Regionen, darunter Westeuropa, Osteuropa, Asien, den Nahen Osten, Afrika, S眉damerika und den S眉dpazifik. Dieser strategische Schritt, zusammen mit dem k眉rzlich bekannt gegebenen Avantor Vertriebsvertrag f眉r Nordamerika, zielt darauf ab, die globale Einf眉hrung ihres Produkts 笔濒补迟颈苍耻尘庐 zu beschleunigen und das Umsatzwachstum ab 2025 voranzutreiben. Das Unternehmen konzentriert sich darauf, den Zugang f眉r Forschungskunden weltweit durch diese Partnerschaften zu erweitern.
- Expansion to 15 international distribution partners across multiple global regions
- Strategic partnership with Avantor for North American distribution
- Positioning for revenue growth starting 2025
- Revenue impact not expected until 2025
Insights
Expands Distribution Network to Accelerate Global Adoption of Platinum庐
The commercial distribution network includes further expansion across
鈥淲e have made significant progress in expanding our international distribution network over the last several months, assembling an outstanding network of partners that are well positioned to drive adoption of Platinum,鈥� said Jeff Hawkins, President and Chief Executive Officer of Quantum-Si. 鈥淲e believe that this expansion will position the Company for continued revenue growth in 2025 and beyond. These distribution partners, along with our recent announcement of the in
About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company鈩�, is focused on revolutionizing the growing field of proteomics. The Company鈥檚 Platinum庐 instrument enables Next-Gen Protein Sequencing鈩� that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at or follow us on or .
Forward Looking Statements
This press release includes 鈥渇orward-looking statements鈥� within the meaning of the 鈥渟afe harbor鈥� provisions of the United States Private Securities Litigation Reform Act of 1995. The actual results of the Company may differ from its expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as 鈥渆xpect,鈥� 鈥渆stimate,鈥� 鈥減roject,鈥� 鈥渂udget,鈥� 鈥渇orecast,鈥� 鈥渁nticipate,鈥� 鈥渋ntend,鈥� 鈥減lan,鈥� 鈥渕ay,鈥� 鈥渨ill,鈥� 鈥渃ould,鈥� 鈥渟hould,鈥� 鈥渂elieves,鈥� 鈥減redicts,鈥� 鈥減otential,鈥� 鈥渃ontinue,鈥� and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company鈥檚 expectations with respect to future performance and development and commercialization of products and services. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside the Company鈥檚 control and are difficult to predict. Factors that may cause such differences include, but are not limited to: the inability to maintain the listing of the Company鈥檚 Class A common stock on The Nasdaq Stock Market; the ability of the Company to grow and manage growth profitably and retain its key employees; the Company鈥檚 ongoing leadership transitions; changes in applicable laws or regulations; the ability of the Company to raise financing in the future; the success, cost and timing of the Company鈥檚 product development and commercialization activities; the commercialization and adoption of the Company鈥檚 existing products and the success of any product the Company may offer in the future; the potential attributes and benefits of the Company鈥檚 commercialized Platinum庐 protein sequencing instrument and kits and the Company鈥檚 other products once commercialized; the Company鈥檚 ability to obtain and maintain regulatory approval for its products, and any related restrictions and limitations of any approved product; the Company鈥檚 ability to identify, in-license or acquire additional technology; the Company鈥檚 ability to maintain its existing lease, license, manufacture and supply agreements; the Company鈥檚 ability to compete with other companies currently marketing or engaged in the development or commercialization of products and services that serve customers engaged in proteomic analysis, many of which have greater financial and marketing resources than the Company; the size and growth potential of the markets for the Company鈥檚 products and services, and its ability to serve those markets once commercialized, either alone or in partnership with others; the Company鈥檚 estimates regarding future expenses, future revenue, capital requirements and needs for additional financing; the Company鈥檚 financial performance; and other risks and uncertainties described under 鈥淩isk Factors鈥� in the Company鈥檚 most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q and in the Company鈥檚 other filings with the SEC. The Company cautions that the foregoing list of factors is not exclusive. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based.
View source version on businesswire.com:
Investor Contact
Jeff Keyes
Chief Financial Officer
ir@quantum-si.com
Media Contact
Katherine Atkinson, SVP, Commercial Marketing
media@quantum-si.com
Source: Quantum-Si Incorporated
FAQ
What regions are covered in Quantum-Si's (QSI) expanded distribution network?
How many distribution partners does Quantum-Si (QSI) now have globally?
When does Quantum-Si (QSI) expect revenue growth from this expansion?
What is the significance of the Avantor agreement for Quantum-Si (QSI)?
